Sort by
4 Nov 2026 • 10:27 AM
Notification of cessation of securities - ACR
4 Nov 2026 • 10:26 AM
Application for quotation of securities - ACR
23 Oct 2026 • 8:20 AM
Notice of Annual General Meeting/Proxy Form
19 Oct 2026 • 3:00 PM
Application for quotation of securities - ACR
19 Oct 2026 • 9:39 AM
Quarterly Activities/Appendix 4C Cash Flow Report
12 Oct 2026 • 9:30 AM
FDA clears regulatory pathway for Female Testosterone MDTS
9 Oct 2026 • 8:51 AM
Webinar, Monday 12 October 2026 - Female Testosterone MDTS
2 Oct 2026 • 8:22 AM
Acrux has received $1.977m RDTI rebate for FY26
24 Sep 2026 • 8:29 AM
Application for quotation of securities - ACR
14 Sep 2026 • 9:21 AM
AGM date, closing date for director nominations